Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | STX-721 |
Synonyms | |
Therapy Description |
STX-721 inhibits EGFR exon 20 mutations, potentially resulting in decreased tumor growth (Eur J Cancer 2022 Vol 174, Suppl 1:S29-S30). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
STX-721 | STX 721|STX721 | EGFR Inhibitor (Pan) 62 | STX-721 inhibits EGFR exon 20 mutations, potentially resulting in decreased tumor growth (Eur J Cancer 2022 Vol 174, Suppl 1:S29-S30). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06043817 | Phase Ib/II | STX-721 | First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations | Recruiting | USA | NLD | FRA | ESP | DEU | 1 |